First Manhattan
ARRY

First Manhattan’s Array Biopharma Inc ARRY Stock Holding History

First Manhattan’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,099,801
Closed -$4.64M – 1480
2015
Q4 		$4.64M Sell
1,099,801
-96,699
-8% -$441K 0.03% 246
2015
Q3 		$5.46M Sell
1,196,500
-385,000
-24% -$2.28M 0.04% 221
2015
Q2 		$11.4M Sell
1,581,500
-38,500
-2% -$284K 0.07% 163
2015
Q1 		$11.9M Buy
1,620,000
+320,000
+25% +$2.28M 0.07% 160
2014
Q4 		$6.15M Buy
+1,300,000
New +$5.14M 0.03% 229
2013
Q4 		– Sell
-65,000
Closed -$404K – 1436
2013
Q3 		$404K Hold
65,000
– – ﹤0.01% 533
2013
Q2 		$406K Buy
+65,000
New +$350K ﹤0.01% 536

Other funds holding ARRY

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

First Manhattan's ARRY Position: Q1 2016 in Review

First Manhattan sold out of Array Biopharma Inc (ARRY) in Q1 2016, closing a stake of 1,099,801 shares — an estimated $4.64M sold.

First Manhattan first reported a position in ARRY in Q2 2013 and held it in 7 quarters. The position peaked at $11.9M in Q1 2015. 132 funds tracked by Wall St. Rank hold ARRY as of Q1 2016.

  • First Manhattan reported no remaining Array Biopharma Inc position as of Q1 2016 after selling out during the quarter.
  • First Manhattan sold 1,099,801 Array Biopharma Inc shares in Q1 2016, an estimated $4.64M.
  • First Manhattan first reported a position in Array Biopharma Inc in Q2 2013 and held it in 7 quarters.
  • First Manhattan's Array Biopharma Inc position peaked at $11.9M in Q1 2015.
  • 132 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2016.

Based on First Manhattan's 13F filing for Q1 2016, filed 22 Apr 2016.